652 related articles for article (PubMed ID: 22544865)
1. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.
Koppaka V; Thompson DC; Chen Y; Ellermann M; Nicolaou KC; Juvonen RO; Petersen D; Deitrich RA; Hurley TD; Vasiliou V
Pharmacol Rev; 2012 Jul; 64(3):520-39. PubMed ID: 22544865
[TBL] [Abstract][Full Text] [Related]
2. Possible role of liver cytosolic and mitochondrial aldehyde dehydrogenases in acetaldehyde metabolism.
Klyosov AA; Rashkovetsky LG; Tahir MK; Keung WM
Biochemistry; 1996 Apr; 35(14):4445-56. PubMed ID: 8605194
[TBL] [Abstract][Full Text] [Related]
3. Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1).
Yang SM; Yasgar A; Miller B; Lal-Nag M; Brimacombe K; Hu X; Sun H; Wang A; Xu X; Nguyen K; Oppermann U; Ferrer M; Vasiliou V; Simeonov A; Jadhav A; Maloney DJ
J Med Chem; 2015 Aug; 58(15):5967-78. PubMed ID: 26207746
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.
Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J
Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenases and cell proliferation.
Muzio G; Maggiora M; Paiuzzi E; Oraldi M; Canuto RA
Free Radic Biol Med; 2012 Feb; 52(4):735-46. PubMed ID: 22206977
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes.
Klyosov AA
Biochemistry; 1996 Apr; 35(14):4457-67. PubMed ID: 8605195
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity.
Yang SM; Martinez NJ; Yasgar A; Danchik C; Johansson C; Wang Y; Baljinnyam B; Wang AQ; Xu X; Shah P; Cheff D; Wang XS; Roth J; Lal-Nag M; Dunford JE; Oppermann U; Vasiliou V; Simeonov A; Jadhav A; Maloney DJ
J Med Chem; 2018 Jun; 61(11):4883-4903. PubMed ID: 29767973
[TBL] [Abstract][Full Text] [Related]
8. Role of aldehyde dehydrogenase isozymes in the defense of rat lens and human lens epithelial cells against oxidative stress.
Choudhary S; Xiao T; Vergara LA; Srivastava S; Nees D; Piatigorsky J; Ansari NH
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):259-67. PubMed ID: 15623782
[TBL] [Abstract][Full Text] [Related]
9. Expression pattern, ethanol-metabolizing activities, and cellular localization of alcohol and aldehyde dehydrogenases in human large bowel: association of the functional polymorphisms of ADH and ALDH genes with hemorrhoids and colorectal cancer.
Chiang CP; Jao SW; Lee SP; Chen PC; Chung CC; Lee SL; Nieh S; Yin SJ
Alcohol; 2012 Feb; 46(1):37-49. PubMed ID: 21940137
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases.
Khanna M; Chen CH; Kimble-Hill A; Parajuli B; Perez-Miller S; Baskaran S; Kim J; Dria K; Vasiliou V; Mochly-Rosen D; Hurley TD
J Biol Chem; 2011 Dec; 286(50):43486-94. PubMed ID: 22021038
[TBL] [Abstract][Full Text] [Related]
11. Ocular aldehyde dehydrogenases: protection against ultraviolet damage and maintenance of transparency for vision.
Chen Y; Thompson DC; Koppaka V; Jester JV; Vasiliou V
Prog Retin Eye Res; 2013 Mar; 33():28-39. PubMed ID: 23098688
[TBL] [Abstract][Full Text] [Related]
12. A patent review on aldehyde dehydrogenase inhibitors: an overview of small molecule inhibitors from the last decade.
Kundu B; Iyer MR
Expert Opin Ther Pat; 2023 Oct; 33(10):651-668. PubMed ID: 38037334
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents.
Dinavahi SS; Gowda R; Bazewicz CG; Battu MB; Lin JM; Chitren RJ; Pandey MK; Amin S; Robertson GP; Gowda K
Eur J Med Chem; 2020 Feb; 187():111962. PubMed ID: 31887569
[TBL] [Abstract][Full Text] [Related]
14. Murine hepatic aldehyde dehydrogenase 1a1 is a major contributor to oxidation of aldehydes formed by lipid peroxidation.
Makia NL; Bojang P; Falkner KC; Conklin DJ; Prough RA
Chem Biol Interact; 2011 May; 191(1-3):278-87. PubMed ID: 21256123
[TBL] [Abstract][Full Text] [Related]
15. Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1.
Morgan CA; Hurley TD
Chem Biol Interact; 2015 Jun; 234():29-37. PubMed ID: 25450233
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde Dehydrogenase Inhibitors for Cancer Therapeutics.
Dinavahi SS; Bazewicz CG; Gowda R; Robertson GP
Trends Pharmacol Sci; 2019 Oct; 40(10):774-789. PubMed ID: 31515079
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenases and their role in carcinogenesis.
Lindahl R
Crit Rev Biochem Mol Biol; 1992; 27(4-5):283-335. PubMed ID: 1521460
[TBL] [Abstract][Full Text] [Related]
18. Rat liver constitutive and phenobarbital-inducible cytosolic aldehyde dehydrogenases are highly homologous proteins that function as distinct isozymes.
Kathmann EC; Naylor S; Lipsky JJ
Biochemistry; 2000 Sep; 39(36):11170-6. PubMed ID: 10998257
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial aldehyde dehydrogenase, a potential drug target for protection of heart and brain from ischemia/reperfusion injury.
Luo XJ; Liu B; Ma QL; Peng J
Curr Drug Targets; 2014; 15(10):948-55. PubMed ID: 25163552
[TBL] [Abstract][Full Text] [Related]
20. Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells.
Vasiliou V; Thompson DC; Smith C; Fujita M; Chen Y
Chem Biol Interact; 2013 Feb; 202(1-3):2-10. PubMed ID: 23159885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
